This National Academies public workshop, which was co-hosted by the Forum on Drug Discovery, Development and Translation, and the Forum on Neuroscience and Nervous System Disorders, provided a venue for professionals who typically diagnose ADHD, drug developers, researchers, people with lived experience, and other stakeholders to discuss the diagnosis and treatment of adults with ADHD, explore challenges and opportunities for drug development, and consider strategies for assessing the risks and benefits of ADHD medication treatment in adult populations. The workshop was supported, in part, through a grant (PAR-23-072) from the Center for Drug Evaluation and Research at the FDA.
The public workshop featured invited presentations and discussions to:
- Discuss the criteria for diagnosis and treatment of adults with ADHD, considering health disparities and the lived experience of adults with ADHD.
- Consider what is known and unknown about the risks and benefits of ADHD medication use in adult populations.
- Share perspectives on the causes, perceptions, consequences, and health equity implications of non-medical use of prescription stimulants, including misuse potential, overdosage, and toxicity.
- Explore challenges and opportunities for the development of new and improved therapeutics for the treatment of ADHD.
- Consider potential strategies for assessing the risks and benefits of ADHD medication treatment in adult populations, including the intersection with opioid use, that support the public health goal of safely and effectively treating adults with ADHD.
Resource
Adult ADHD Resources Spreadsheet
This spreadsheet contains select resources for adults with ADHD, educators, and healthcare professionals that were mentioned and/or discussed during the workshop Adult Attention-Deficit/Hyperactivity Disorder: Diagnosis, Treatment, and Implications for Drug Development. It is a non-exhaustive list of current resources compiled by the National Academies' staff to help inform workshop participants. Supplemented by input from interested partners, staff collected the names and titles of resources mentioned during the workshop aimed at supporting those with ADHD, their families, loved ones, and caregivers. Following the workshop, the spreadsheet may be updated with relevant resources. On the spreadsheet, use the "Filter" at the top of the screen to search and sort data.
Planning Committee
Carlos Blanco (co-chair), National Institute on Drug Abuse, NIH
Craig Surman (co-chair), Massachusetts General Hospital; Harvard Medical School
Amy Arnsten, Yale University School of Medicine
Andrea Chronis-Tuscano, University of Maryland
Taleed El-Sabawi, Florida International University
Evelyn Polk Green, Attention Deficit Disorder Association; Children and Adults with Attention-Deficit/Hyperactivity Disorder
Steve Lee, University of California, Los Angeles
James (Jimmy) Leonard, University of Maryland School of Pharmacy; Maryland Poison Center
Tamara Rosier, ADHD Coaches Organization; ADHD Center of West Michigan
Matthew Rudorfer, National Institute of Mental Health, NIH
Almut Winterstein, University of Florida
Stevin Zorn, MindImmune Therapeutics